|
|
|
|
|
|
|
|
20.03.25 - 21:09
|
Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2024 Financial Results and Business Highlights (Business Wire)
|
|
-- Year-over-year revenues grew 56% in Q4 and 13% for full year --
-- Zola® year-over-year revenues increased 124% in Q4 and 46% for full year --
-- Company plans business combination with Roosevelt Resources, Inc. --
DALLAS--(BUSINESS WIRE)--Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the fourth quarter and full year of 2024.
“We are extremely pleased with the progress we made in 2024, particularly in the second half of the year following the sale of our GoodWheat™ assets,” said T.J. Schaefer, president and CEO. “Our focus on Zola® coconut water led to 80 percent revenue growth for the brand in the back half of the year and drove total Arcadia revenue growth above 30 percent. At the same time revenue growth was accelerating, we maintained tight cost controls, resulting in the lowest use of cash from operations since Arcadia went public a decade ago.
“In the fo...
|
|
|
06.03.25 - 14:03
|
Arcadia Biosciences (RKDA) Announces Date of Fourth Quarter 2024 Financial Results and Business Highlights Conference Call (Business Wire)
|
|
DALLAS--(BUSINESS WIRE)--Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the fourth quarter and full year of 2024 after market close on March 20, 2025.
The company has scheduled a conference call for 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss fourth-quarter and year-end results and key strategic achievements. Interested participants can join the conference call using the following options:
An audio-only webcast of the conference call will be available, with a link posted in the Investors section of Arcadia's website.
To join the live call, please register here, and a dial-in number and unique PIN will be provided.
Following completion of the call, a recorded replay will be available in the Investors Section of the company's website.
About Arcadia Biosciences, Inc.
Since 2002, Arcadia Biosciences (Nasdaq: RKDA) has been innovating high-va...
|
|
24.02.25 - 18:24
|
XFRA : Diverse Instrumente: Aussetzung/Suspension (XETRA)
|
|
DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:
THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL
CASTOR MARITIME INC. 1C1 MHY1146L2082 BAW/UFN
AFFIMED N.V. EO-,10 A28A NL0015001ZQ0 BAW/UFN
AETHLON MEDIC.NEW DL-,001 EJU0 US00808Y4061 BAW/UFN
AMERICAN R.H. NEW DL-,001 B0Y US02919L5057 BAW/UFN
ARCADIA BIOSC.NEW.DL-,001 17D US0390143032 BAW/UFN
ENERGY FOCUS INC. DL-0001 FI4A US29268T5083 BAW/UFN
KARTOON STUD. NEW DL-,001 4XV0 US37229T5092 BAW/UFN
HOUSTON AMERN ENE.DL-,001 8H6H US44183U2096 BAW/UFN
ZOOMCAR HLDGS NEW DL-,001 EO30 US45784G2003 BAW/UFN
MARIN SOFTWARE DL -,001 2MA US56804T3041 BAW/UFN
NOVA LIFESTYLE DL-,01 15N US66979P3001 BAW/UFN
PLUS THERAPEUTICS ...
|
|
|
|
|
|
|
|
|
|
|